Michelle Gan
Corporate Officer/Principal presso Malaysian Institute of Accountants
Profilo
Michelle Gan is a member of the Arizona Society of Certified Public Accountants and the Malaysian Institute of Accountants.
She previously worked as a Finance Manager at StemLife Bhd., an Auditor at Deloitte Touche Tohmatsu LLC, a Principal at Malaysian Biotechnology Corp.
Sdn.
Bhd., a Chief Financial Officer at Sentinext Therapeutics Sdn.
Bhd., and a Principal at Neuroweb Sdn.
Bhd.
She obtained her undergraduate degree from the University of Southern Queensland in 1996.
Currently, Ms. Gan holds positions at the Arizona Society of Certified Public Accountants and the Malaysian Institute of Accountants.
Posizioni attive di Michelle Gan
| Società | Posizione | Inizio |
|---|---|---|
Malaysian Institute of Accountants
 Malaysian Institute of Accountants Other Consumer ServicesConsumer Services Malaysian Institute of Accountants develops, supports and enhances the integrity, status and interests of the profession in Malaysia. It offers educational services to the members. The company is headquartered in Kuala Lumpur, Malaysia. | Corporate Officer/Principal | - |
| Arizona Society of Certified Public Accountants | Corporate Officer/Principal | - |
Precedenti posizioni note di Michelle Gan
| Società | Posizione | Fine |
|---|---|---|
| Neuroweb Sdn. Bhd. | Corporate Officer/Principal | - |
Malaysian Biotechnology Corp. Sdn. Bhd.
 Malaysian Biotechnology Corp. Sdn. Bhd. BiotechnologyHealth Technology Malaysian Biotechnology Corp. Sdn. The private company is based in Kuala Lumpur, Malaysia, and has subsidiaries in Malaysia. Bhd. operates as an economic development agency for the bio-based industry. | Corporate Officer/Principal | - |
Deloitte Touche Tohmatsu LLC
 Deloitte Touche Tohmatsu LLC Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu LLC engages in the provision of accounting services. The company was founded in May 1968 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | - |
| STEMLIFE BERHAD | Direttore Finanziario/CFO | - |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Direttore Finanziario/CFO | - |
Formazione di Michelle Gan
| University of Southern Queensland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
StemLife Bhd.
 StemLife Bhd. Medical/Nursing ServicesHealth Services StemLife Bhd. operates as an investment holding company, which engages in the provision of stem cells therapy and stem cell consultancy services. It operates its business through the following segments: Provision of Collection, Testing, Processing and Preservation of UCBSC, UCT & PBSC. The company was founded by Low Su-Shing, Lim Oi Wah, and Aw Tar Choon on December 13, 2001 and is headquartered in Kuala Lumpur, Malaysia. | Health Services |
| Arizona Society of Certified Public Accountants | |
Deloitte Touche Tohmatsu LLC
Deloitte Touche Tohmatsu LLC Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu LLC engages in the provision of accounting services. The company was founded in May 1968 and is headquartered in Tokyo, Japan. | Commercial Services |
Malaysian Biotechnology Corp. Sdn. Bhd.
Malaysian Biotechnology Corp. Sdn. Bhd. BiotechnologyHealth Technology Malaysian Biotechnology Corp. Sdn. The private company is based in Kuala Lumpur, Malaysia, and has subsidiaries in Malaysia. Bhd. operates as an economic development agency for the bio-based industry. | Health Technology |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
| Neuroweb Sdn. Bhd. |
- Borsa valori
- Insiders
- Michelle Gan
